High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs

Documenti analoghi

• Genome‐wide loss‐of‐function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus‐integrated hepatoma cells
  di: Makoto Fukuoka, et al.
  Pubblicazione: (2024)
• The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs
  di: Kazuhiro Murai, et al.
  Pubblicazione: (2025)
• Lymphocyte‐to‐Monocyte Ratio as a Practical Biomarker for Immunotherapy Response in Hepatocellular Carcinoma
  di: Satoshi Tanaka
  Pubblicazione: (2025)
• Negative Real Balance Effects in the Presence of Involuntary Unemployment
  di: Yasuhito Tanaka
  Pubblicazione: (2021)
• Fiscal Policy as a Solution to Involuntary Unemployment
  di: Yasuhito Tanaka
  Pubblicazione: (2021)